Journal of Cancer 

3.2
Impact Factor





 ISSN: 1837-9664
  • Home
  • About
  • For Authors
  • Submit Manuscript
  • Login
  • Contact
Account
  • Current Issue
  • Volume 16; 2025
  • Volume 15; 2024
  • Volume 14; 2023
  • Volume 13; 2022
  • Volume 12; 2021
  • Archive
  • Editorial Board
  • Cover Images
  • Index & Coverage
  • Special Issues

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

PubMed Central

open access Global reach, higher impact

◂ Last issue Archive   

Volume 16 (13); 2025

Research Paper

Graphic abstract

Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma
Ryan J. Sullivan, Katy K. Tsai, Anna C. Pavlick, Elizabeth I. Buchbinder, Sanjiv S. Agarwala, Antoni Ribas, Johan Jansson, Guillermo Rossiter, Anthony J. Olszanski
J. Cancer 2025; 16(13): 3797-3809. doi:10.7150/jca.117878
Full text PDF

Popup Image

©2025 Ivyspring International Publisher. Terms of use